Now here’s the best of what YOU had to say:
End of J&J stent business carries lessons for medical device innovators. “Last week’s news that J&J is abandoning their coronary stent business was sad, but provided several lessons about poor product development execution and the need for constant innovation.”
Electronic medical health records: Making data useful for patients. “If we’re going to change the culture so that patients demand personal health records and stewardship of their own data, we need to make the tools usable!”
Healthcare business funding could be derailed by weak IPO market. Venture capitalists have a message for healthcare entrepreneurs, and it reads like this: “If you’re considering an initial public offering, don’t.” That’s on the footsteps of a new study from Deloitte and the National Venture Capital Association.
Medical device industry to FDA: No user fee hikes until goals met. “The medical device industry is asking the FDA to take a couple more years to meet goals it says the watchdog agency has failed to meet before it agrees on reauthorizing user fees for another go-around.”
What is a ‘Patient Encounter’ in the World of Meaningful Use? “The CMS EHR Incentive Programs are now in full swing and numerous eligible professionals have already received substantial Stage 1 payments. HIT adoption, fueled by rewarding the ’meaningful use of certified technology’, is moving forward as planned. However, there are still a few outstanding items that can cause difficulty for some EPs, especially specialists.”